Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Health Service employment freeze

This article was originally published in The Rose Sheet

Executive Summary

Health and Human Services Assistant Secretary for Health Philip Lee imposes a temporary employment freeze throughout PHS effective Dec. 8, including a moratorium on promotions to the GS- 14 level. Citing an increase in PHS employment despite established targets for reduced full-time equivalent (FTE) staffing for fiscal 1994 and 1995, Lee explains in a memo to PHS agency heads that "this freeze will enable PHS to restrict hiring pending final FY 1994 and FY 1995 FTE levels and to assess total employment in light of the Vice President's National Performance Review (NPR) and the President's Executive Order to reduce federal employment." During the freeze period, Lee's staff will meet with agency heads to discuss the development of their plans to meet employment targets, including a 12% staffing reduction by FY 1999

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel